Researchers at the Royal College of Surgeons (RCSI) in Ireland have found new genes linked to epilepsy which could inform the development of new treatments for the condition
Integrated research can help understand the physiological pathways of alcoholic liver disease, says Dr Shilpa Chokshi, of the Foundation for Liver Research
The European Society of Intensive Care Medicine’s priorities for intensive care medicine in Europe and beyond are introduced here, focussing on sepsis research, other current research and practice in the field, as well as equality and diversity
Dr Gerry Morrow shares his thoughts on the current state of play when it comes to the early diagnosis of neurodegenerative disorders, and asks the questions, can we screen, and should we screen?
Clinicians in across the UK are being urged by the British Acupuncture Council to consider referring their patients for acupuncture to treat a range of different conditions
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group provides a market perspective on the diabetes monitoring and drug delivery innovation fields and explains why these are a scenario for big technology synergy
The vital work of the National Institute on Deafness and Other Communication Disorders (NIDCD) and The National Institute of Neurological Disorders and Stroke (NINDS) are explored here by Open Access Government, with a special focus on neurodegenerative disorders.
Paulus Carpelan, Vice President at Quattro Folia Oy argues that now is the time to rethink healthcare when it comes to the treatment of people with diabetes.
Researchers at Cleveland Clinic, University of Oxford, and University of Erlangen have identified a novel imaging biomarker – and found it can be used to predict all-cause and cardiac mortality by measuring inflammation of fatty tissue surrounding the coronary arteries
Naoko Tanese from New York University School of Medicine outlines their work around Huntington’s disease (HD) and new targets for therapeutic intervention
Colin Capper, Head of Research Development and Evaluation at Alzheimer’s Society, discusses why greater investment is needed in today’s dementia care research
